Ovid Therapeutics (NasdaqGS:OVID) 2026 Conference Transcript

Ovid Therapeutics (NasdaqGS:OVID) 2026 Conference March 11, 2026 03:00 PM ET Company ParticipantsMeg Alexander - President and CEOConference Call ParticipantsMarc Goodman - Senior Biopharma AnalystMarc GoodmanPharma analyst at Leerink, we are lucky enough to have the CEO, Meg Alexander of Ovid Therapeutics, with us. Thank you very much for joining us.Meg AlexanderMy pleasure.Marc GoodmanFun time being CEO? Is it more fun being CEO?Meg AlexanderWell, it was fun being the COO.Marc GoodmanHow long have you bee ...